[A morphological study of pulmonary macrophages in bleomycin-injected murine models]
1Department of Medicine II, Niigata University School of Medicine, Japan.
Abstract:
Pulmonary changes induced in a murine model by intraperitoneal injections of bleomycin were morphologically studied by light and electron microscopy. The number of pulmonary macrophages and the distribution of fibronectin in these cells were evaluated by acid phosphatase and affinity staining using anti-fibronectin horseradish peroxidase conjugates. The onset of acute inflammation occurred 4 days after intraperitoneal injection of bleomycin and reached its peak on the 14th day post-injection. The inflammatory reaction then gradually decreased. Areas of subpleural fibrosis was observed on day 42. On day 14, the ratio of the macrophage in bleomycin-treated mice to that in control mice was 5:1. Many activated and foamy macrophages were observed at that time. These findings indicate that macrophage turnover activity is remarkably increased during the acute inflammatory phase. Fibronectin was detected in the cytoplasm of macrophages on day 14, 21, and 28. It was also detected in both alveolar capillary and epithelial basal lamina as well as in interstitial collagen fibers. On day 42, fibronectin staining was strongly positive in areas of subpleural fibrosis. These results suggest that fibronectin released from pulmonary macrophages plays a role in the process of pulmonary fibrosis.
Insights
Bleomycin induces pulmonary inflammation and fibrosis in mice, marked by increased macrophage activity and fibronectin deposition. Macrophages release fibronectin, contributing to the development of lung fibrosis.
Area of Science:
- Pulmonary pathology
- Immunohistochemistry
- Fibrosis research
Context:
- Bleomycin is a chemotherapeutic agent that can induce lung injury.
- Pulmonary fibrosis is a progressive and often fatal lung disease.
- Macrophages play a critical role in tissue repair and fibrosis.
Purpose:
- To investigate the role of macrophages and fibronectin in bleomycin-induced pulmonary fibrosis.
- To characterize the temporal changes in pulmonary inflammation and fibrosis.
Summary:
- Bleomycin administration in mice led to acute pulmonary inflammation peaking at 14 days, followed by subpleural fibrosis by day 42.
- Macrophage numbers increased fivefold by day 14, with activated and foamy macrophages observed.
- Fibronectin was detected in macrophages and extracellular matrix components, particularly in fibrotic areas, suggesting macrophage-derived fibronectin contributes to fibrosis.
Impact:
- This study highlights the significant role of pulmonary macrophages and fibronectin in the pathogenesis of bleomycin-induced lung fibrosis.
- Findings provide insights into potential therapeutic targets for pulmonary fibrosis.
